Zeke Capital Advisors, LLC Neurocrine Biosciences Inc Transaction History

Zeke Capital Advisors, LLC

  • $1.53 Billion
  • Q4 2022

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$92.03 - $107.81 $36,627 - $42,908
-398 Reduced 12.45%
2,798 $297,000
Q2 2022

Aug 09, 2022
SELL
$75.79 - $100.07 $67,149 - $88,662
-886 Reduced 21.71%
3,196 $312,000
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $16,156 - $21,142
-223 Reduced 5.18%
4,082 $383,000
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $23,656 - $31,547
297 Added 7.41%
4,305 $367,000
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $46,709 - $53,674
542 Added 15.64%
4,008 $384,000
Q2 2021

Aug 16, 2021
BUY
$89.43 - $102.27 $43,731 - $50,010
489 Added 16.43%
3,466 $337,000
Q1 2021

Apr 21, 2021
BUY
$87.57 - $119.4 $28,372 - $38,685
324 Added 12.21%
2,977 $290,000
Q4 2020

Feb 10, 2021
BUY
$86.91 - $108.33 $230,572 - $287,399
2,653 New
2,653 $254,000
Q3 2020

Nov 09, 2020
SELL
$96.16 - $135.15 $184,434 - $259,217
-1,918 Closed
0 $0
Q2 2020

Jul 21, 2020
BUY
$85.09 - $130.36 $163,202 - $250,030
1,918 New
1,918 $234,000
Q2 2019

Jul 24, 2019
SELL
$72.24 - $91.27 $613,678 - $775,338
-8,495 Closed
0 $0
Q1 2019

Apr 29, 2019
BUY
$69.31 - $91.53 $180,552 - $238,435
2,605 Added 44.23%
8,495 $748,000
Q4 2018

Feb 11, 2019
BUY
$68.32 - $124.36 $402,404 - $732,480
5,890 New
5,890 $421,000

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email